Bridging the Gap Between Innovation and Capital
OrbiMed Advisors
Focus on therapeutic companies
Program
Calling all therapeutics companies!
OrbiMed is a global, multi-stage healthcare investment firm. Its private investment strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders.
Event
LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with OrbiMed.
Applications will be selected based on meeting the following criteria:
Geography:
Not restricted.
Company type:
Therapeutics companies; late preclinical or clinical stage.
Areas of Interest:
- Therapeutics
- Human
- Therapeutic modalities of interest include, (but not limited to):
- Small Molecules
- Biologics
- Genetic Medicines
- Research areas of interest include, (but not limited to):
- Oncology
- Immunology
- Cardiovascular
- Renal
Stage:
Companies seeking Series A, Series B or later funding.
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.